{
  "id": 1834948,
  "title": "Kestra Medical Technologies CEO Webster sells $412,180 in stock",
  "url": "https://urgent.news/2026/08/19/kestra-medical-technologies-ceo-webster-sells-412-180-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-19T00:01:12.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/kestra-medical-technologies-ceo-webster-sells-412180-in-stock-93CH-4866248"
  },
  "original_language": "en",
  "account": "Kestra Medical Technologies CEO Brian Daniel Webster divested 15,000 shares of the company's stock on August 17, 2026. The transaction totaled $412,180, with shares exchanged at a weighted average price of $27.4787. This sale adhered to a Rule 10b5-1 trading plan adopted by Webster in September 2025. KMTS stock had been trading near its 52-week high of $30.00, having increased by 78% over the past year. After the sale, Webster retained 460,215 shares directly. As President and CEO, he also serves on the company's Board of Directors. Kestra Medical Technologies, valued at $1.63 billion, remains unprofitable with a loss of $2.43 per share over the past year. Despite strong revenue growth in the fiscal fourth quarter of 2026, the company missed earnings expectations, posting an EPS loss of $0.67 compared to the estimated loss of $0.58. Market analysts have shown a mixed interest in Kestra Medical Technologies, with JPMorgan and Oppenheimer initiating coverage with a bullish Overweight and Perform rating, respectively, while Wolfe Research raised its price target to $30.00 and maintained an Outperform rating.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "RCM Technologies CFO Kevin Miller sells $3.48m in shares",
        "url": "https://urgent.news/2026/08/18/rcm-technologies-cfo-kevin-miller-sells-3-48m-in-shares",
        "published": "2026-08-18T23:31:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}